Clinical Trial Update: Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye [Phase 3]

View source ↗

Summary

Phase 3 trial comparing PRO-148 to Systane in mild to moderate dry eye completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• PRO-148
• Systane

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Dry Eye | Phase 3 | Status: COMPLETED | Results posted: 2017-12-15